Support for cancer research through biostatistics and computational biology
Official title: Bio statistics Core
Funded at Dana-Farber Cancer Inst · NIH-11070330 · Data updated 2026-11-12
This study is all about helping researchers understand endometrial cancer better by combining lab results with patient information, and it's designed for anyone involved in cancer research who wants to improve how they collect and analyze data.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | May 1, 2024 |
| Project end | April 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $183,615 |
| NIH project number | 5P01CA269021-02 |
| Project ID | NIH-11070330 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals involved in clinical trials for cancer, particularly those with endometrial cancer.
✕Less likely to help
Patients not involved in cancer research or those with conditions unrelated to the focus of this biostatistical support may not benefit from this research.
What this research studies
This research focuses on providing essential statistical and computational biology support for various cancer-related projects. The team, led by Dr. Nabihah Tayob, will assist in the design and analysis of clinical and preclinical studies, ensuring that data collection and management are handled effectively. By integrating laboratory results with clinical outcomes, the core aims to enhance the understanding of cancer, particularly endometrial cancer, and develop new statistical methods for research challenges.
Why it matters
Potential benefit: If successful, this research could lead to improved methodologies for cancer treatment and better patient outcomes.
How similar studies have gone: Previous research has shown that biostatistical support significantly enhances the quality and outcomes of cancer studies, indicating a strong potential for success in this approach.
Where this research is happening
-
Dana-Farber Cancer Inst
Boston, United States Active
Researchers
- Principal investigator: Tayob, Nabihah — Dana-Farber Cancer Inst
- Study coordinator: Tayob, Nabihah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.